GlassScriptPhysician profile
Anne M Bacon
NPI 1801865779
$869.40
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $188.44 | 2019 | |
| Radius Health, INC. | $113.44 | 2019 | |
| Abbvie INC. | $107.96 | 2019 | |
| Janssen Biotech, INC. | $95.63 | 2019 | |
| Pacira Therapeutics, INC. | $72.21 | 2019 | |
| Mallinckrodt Enterprises LLC | $58.73 | 2019 | |
| Glaxosmithkline, LLC. | $57.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.00 | 2019 | |
| Depuy Synthes Sales INC. | $32.03 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.09 | 2019 | |
| Ucb, INC. | $22.85 | 2019 | |
| Sobi, INC | $22.54 | 2019 | |
| Pfizer INC. | $22.27 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.